Zacks Company Profile for Ra Medical Systems, Inc. (RMED : AMEX) |
|
|
|
Company Description |
Ra Medical Systems, Inc. is a commercial-stage medical device company. It develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company's product pipeline consists of DABRA which is a minimally-invasive excimer laser and disposable catheter system used by physicians as a tool in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease, a form of peripheral artery disease, or above- and below-the-knee. Pharos Excimer Laser is a powerful 308 nm ultraviolet-B excimer laser used by physicians as a tool to treat chronic skin diseases, including psoriasis, vitiligo, atopic dermatitis and leukoderma. Ra Medical Systems, Inc. is based in Carlsbad, California.
Number of Employees: 58 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $0.30 |
Daily Weekly Monthly
 |
20 Day Moving Average: 1,800,416 shares |
Shares Outstanding: 32.30 (millions) |
Market Capitalization: $9.73 (millions) |
Beta: 1.57 |
52 Week High: $9.82 |
52 Week Low: $0.26 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-8.89% |
2.61% |
12 Week |
-15.08% |
-6.65% |
Year To Date |
-80.69% |
-77.83% |
|
|
|
|
|
Address & Contact Information |
Street Address |
Phone / Fax |
Email Address |
Web URL |
2070 Las Palmas Drive - Carlsbad,CA 92011 USA |
ph: 760-804-1648 fax: - |
jcain@lhai.com |
http://www.ramed.com |
|
|
|
General Corporate Information |
Officers
Jonathan Will McGuire - Director and Chief Executive Officer
Martin Colombatto - Chairman
Andrew Jackson - Chief Financial Officer
Richard Mejia, Jr. - Director
Susanne Meline - Director
|
|
Peer Information
Ra Medical Systems, Inc. (ABMD)
Ra Medical Systems, Inc. (DMDS)
Ra Medical Systems, Inc. (CPWY.)
Ra Medical Systems, Inc. (EQUR)
Ra Medical Systems, Inc. (ECIA)
Ra Medical Systems, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 74933X203
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/10/22
|
|
Share - Related Items
Shares Outstanding: 32.30
Most Recent Split Date: 11.00 (0.04:1)
Beta: 1.57
Market Capitalization: $9.73 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-1.70 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/10/22 |
|
|
|
|